CoreAge Rx vs AlphaMD Sermorelin: Monthly Starting Price or Multiweek Quote?

Start with the unit being sold

The CoreAge Rx product page advertises a starting price of $99 per month. “Starting” is a qualification: request the amount for the actual proposed prescription, its supply period, and any separately required services.

The AlphaMD treatment page lists $229.99 for a 10–15 week supply, or $264.99 for California. The duration depends on the provider's recommendation. It is not a fixed monthly quote and should not be converted into a guaranteed monthly bill using the longest possible duration.

Establish eligibility before comparing totals

The AlphaMD shop displays an active-TRT requirement for ancillary medications. Ask whether the sermorelin purchase is available independently and what additional program commitments apply. A separate treatment should not be started simply to gain access to another product.

For CoreAge, ask the corresponding questions about evaluation, eligibility, and charges if prescribing is inappropriate. Our commercial relationship does not remove the need to confirm those details. Read both the CoreAge review and AlphaMD review for the limits of the public information.

Get one estimate for each actual arrangement

Ask each provider to list the initial payment, recurring charges, medication, laboratory requirements, consultations, and any supplies or shipping charged separately. Identify the billing interval and cancellation deadline for each recurring item. A medication purchase and an ongoing membership may stop through different processes.

Then compare the same period using confirmed information. If either provider cannot yet confirm a supply period or a required clinical service, leave that part unresolved rather than inventing an all-in number. Our variable supply guide explains why this matters.

Price cannot answer the clinical question

The FDA's guidance on compounding explains that compounded drugs are not FDA-approved. Neither a low starting price nor a longer advertised supply establishes that a preparation is appropriate or more effective.

Ask what evidence supports the intended goal, what uncertainty remains, and how follow-up decisions will be made. A provider should be able to explain the proposed medication separately from its enrollment terms. The program entry guide can help organize the financial questions before a clinical discussion.

The useful outcome of this comparison is a pair of understandable written offers. We do not have a verified personalized quote or comparative patient-outcome data establishing a clinical winner between these services.